rs4239008
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_023036.6(DNAI2):c.1722+34G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.844 in 506,342 control chromosomes in the GnomAD database, including 185,208 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.77 ( 47068 hom., cov: 26)
Exomes 𝑓: 0.87 ( 138140 hom. )
Consequence
DNAI2
NM_023036.6 intron
NM_023036.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.201
Publications
5 publications found
Genes affected
DNAI2 (HGNC:18744): (dynein axonemal intermediate chain 2) The protein encoded by this gene belongs to the dynein intermediate chain family, and is part of the dynein complex of respiratory cilia and sperm flagella. Mutations in this gene are associated with primary ciliary dyskinesia type 9. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
DNAI2 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-74312264-G-A is Benign according to our data. Variant chr17-74312264-G-A is described in ClinVar as Benign. ClinVar VariationId is 261645.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.769 AC: 114346AN: 148656Hom.: 47065 Cov.: 26 show subpopulations
GnomAD3 genomes
AF:
AC:
114346
AN:
148656
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.867 AC: 124824AN: 144000 AF XY: 0.869 show subpopulations
GnomAD2 exomes
AF:
AC:
124824
AN:
144000
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.875 AC: 312813AN: 357586Hom.: 138140 Cov.: 0 AF XY: 0.874 AC XY: 171097AN XY: 195840 show subpopulations
GnomAD4 exome
AF:
AC:
312813
AN:
357586
Hom.:
Cov.:
0
AF XY:
AC XY:
171097
AN XY:
195840
show subpopulations
African (AFR)
AF:
AC:
4094
AN:
9486
American (AMR)
AF:
AC:
24708
AN:
26680
Ashkenazi Jewish (ASJ)
AF:
AC:
11206
AN:
12712
East Asian (EAS)
AF:
AC:
13258
AN:
15708
South Asian (SAS)
AF:
AC:
49885
AN:
59888
European-Finnish (FIN)
AF:
AC:
27578
AN:
30964
Middle Eastern (MID)
AF:
AC:
1604
AN:
1876
European-Non Finnish (NFE)
AF:
AC:
165949
AN:
183278
Other (OTH)
AF:
AC:
14531
AN:
16994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1868
3737
5605
7474
9342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.769 AC: 114357AN: 148756Hom.: 47068 Cov.: 26 AF XY: 0.771 AC XY: 55803AN XY: 72336 show subpopulations
GnomAD4 genome
AF:
AC:
114357
AN:
148756
Hom.:
Cov.:
26
AF XY:
AC XY:
55803
AN XY:
72336
show subpopulations
African (AFR)
AF:
AC:
17536
AN:
40056
American (AMR)
AF:
AC:
13111
AN:
14886
Ashkenazi Jewish (ASJ)
AF:
AC:
3080
AN:
3462
East Asian (EAS)
AF:
AC:
4154
AN:
4916
South Asian (SAS)
AF:
AC:
3913
AN:
4696
European-Finnish (FIN)
AF:
AC:
8582
AN:
9750
Middle Eastern (MID)
AF:
AC:
246
AN:
294
European-Non Finnish (NFE)
AF:
AC:
61294
AN:
67700
Other (OTH)
AF:
AC:
1643
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
967
1934
2901
3868
4835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
2792
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 9 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.